Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

NCT07281599 is registered in ClinicalTrials.gov with Qurasense as lead sponsor.

NCT NCT07281599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07281599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
Lead sponsor
Qurasense
Phase
Not applicable
Overall status
Recruiting
Start date
December 1, 2025
Completion date
March 31, 2027
Enrollment
450 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer (early detection), cervical cancer cin grade, cervical cancer screening, high risk hpv, hpv, hpv (human papillomavirus)-associated, hpv 16 infection, hpv dna, hpv infection, hpv infections, screening test